Menopausal hormone therapy: Characterising users in an Australian national cross-sectional study

Menopausal hormone therapy (MHT) is effective for menopausal symptoms, however, its use is also associated with risks of serious health conditions including breast, ovarian and endometrial cancer, stroke and venous thromboembolism. MHT-related health risks increase with longer durations of use. In A...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2021-08, Vol.16 (8), p.e0253725-e0253725
Main Authors: Velentzis, Louiza S, Egger, Sam, Banks, Emily, Canfell, Karen
Format: Article
Language:English
Subjects:
Biology and Life Sciences
Breast cancer
Care and treatment
Complications and side effects
Cross-sectional studies
Endocrine therapy
Endometrial cancer
Endometrium
Health risks
Hormone therapy
Hysterectomy
Medicine and Health Sciences
Menopause
Ovarian cancer
Ovariectomy
Patient outcomes
People and Places
Thromboembolism
Uterine cancer
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Menopausal hormone therapy (MHT) is effective for menopausal symptoms, however, its use is also associated with risks of serious health conditions including breast, ovarian and endometrial cancer, stroke and venous thromboembolism. MHT-related health risks increase with longer durations of use. In Australia, while overall MHT use fell when risk-related findings were published in 2002, a significant number of women continue using MHT long-term. We aimed to examine socio-demographic, health-related and lifestyle characteristics in relation to post-2002 MHT use, and to compare use for
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0253725